ArticleIJID regions2022
Burden of COVID-19 and case fatality rate in Pune, India: an analysis of the first and second wave of the pandemic.
Article in IJID regions, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
11 citing papers in PubMed.
- Not all heroes wear capes: a photovoice exploration of youth experiences during and beyond COVID-19.BMC public health · 2026Article
- Interpreting epidemiological surveillance data: a modelling study based on Pune city.Scientific reports · 2025Article
- Conventional and frugal methods of estimating COVID-19-related excess deaths and undercount factors.Scientific reports · 2024Article
- Comparative Study Between the First and Second Wave of COVID-19 Deaths in India: A Single Center Study.Cureus · 2023Article
- Validation of the Fertility Norms Scale and Association with Fertility Intention and Contraceptive Use in India.Studies in family planning · 2023Article
- Overview of COVID-19 mortality in Zoram Medical College, Mizoram: A hospital-based study.Journal of family medicine and primary care · 2023Article
- Parenting stress and associated factors in healthcare workers after the second wave of COVID-19 in India: a two-center cross-sectional study.Frontiers in psychiatry · 2023Article
- Evaluation of immunogenicity post two doses of inactivated SARS-CoV-2 vaccine, Covaxin after six months.Human vaccines & immunotherapeutics · 2022Article
- Epidemiological investigation of the COVID-19 outbreak in Vellore district in South India using Geographic Information Surveillance (GIS).International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases · 2022Article
- Prevalence and Impact of Preexisting Comorbidities on Overall Clinical Outcomes of Hospitalized COVID-19 Patients.BioMed research international · 2022Article
- Detailed phylogenetic analysis tracks transmission of distinct SARS-COV-2 variants from China and Europe to West Africa.Scientific reports · 2021Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: To assess trends in case incidence and fatality rate between the first and second waves, we analyzed programmatic COVID-19 data from Pune city, an epicenter of COVID-19 cases in India. Method: The trends of cases incidence, time-to-death and case fatality rate (CFR) were analyzed. Poisson regression models adjusted for age and gender were used to determine the independent effect of pandemic waves on mortality. Results: Of 465 192 COVID-19 cases, 162 182 (35%) were reported in the first wave and 4146 (2.5%) deaths, and 275 493 (59%) in the second wave and 3184 (1.1%) deaths ( Conclusion: The burden of COVID-19 cases and deaths was more significant in the second wave; however, the CFR declined as the pandemic progressed. Nevertheless, investigating new therapies and implementing mass vaccination against COVID-19 are urgently needed.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.